DIAZEPAM Safety Questions, DIAZEPAM Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about DIAZEPAM. Our extensive database of DIAZEPAM adverse events and DIAZEPAM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about DIAZEPAM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



DIAZEPAM Safety Reports

Total DIAZEPAM reports: 203.
DIAZEPAM FDA safety alerts: 2003 2006 .
Reported deaths: 115    Reported hospitalizations: 44.
Take DIAZEPAM Side Effects Survey or Share Your DIAZEPAM Story. DIAZEPAM Usage.

Showing 1-75 of 203 Next >

Consumer or non-health professional from UNITED KINGDOM reported DIAZEPAM problem on Apr 05, 2007. Female patient, 56 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: dysphagia, parkinsonism, productive cough, rales, weight decreased. DIAZEPAM dosage: 40 MG (10 MG, 4 IN 1 D). During the same period patient was treated with HALOPERIDOL, PROCYCLIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Health Professional from UNITED KINGDOM on Apr 10, 2007. Female patient, 56 years of age, weighting 72.75 lb, was diagnosed with agitation, psychotic disorder and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, aspiration, bradykinesia, cogwheel rigidity, cough, crepitations, dysphagia, dysphonia, extrapyramidal disorder. DIAZEPAM dosage: unknown. During the same period patient was treated with HALOPERIDOL, PROCYCLIDINE HYDROCHLORIDE, FLUPENTIXOL, PREDNISOLONE, AZATHIOPRINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Apr 11, 2007. Male patient, 44 years of age, was diagnosed with convulsion and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: nervousness, panic attack. DIAZEPAM dosage: unknown. During the same period patient was treated with VIAGRA, PHENYTOIN. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2007. Male patient, 21 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: alcohol use, incorrect dose administered. DIAZEPAM dosage: 130 MG; X1. Patient died.

Health Professional from GERMANY reported DIAZEPAM problem on May 04, 2007. Female patient, 70 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, alanine aminotransferase increased, delirium, disorientation, gamma-glutamyltransferase increased, hepatic enzyme increased, hypertension, mood swings, panic attack. DIAZEPAM dosage: 54 MG/DAY. During the same period patient was treated with MELPERONE, MIRTAZAPINE, CARBAMAZEPINE. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, 45 years of age, weighting 104.0 lb, was diagnosed with anxiety, convulsion and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: epilepsy, refusal of treatment by patient, treatment noncompliance. DIAZEPAM dosage: 5 MG; AS NEEDED; ORAL. During the same period patient was treated with ESTROGENS CONJUGATED, LEVOTHYROXINE, MORPHINE SULPHATE, OXCARBAZEPINE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported DIAZEPAM problem on May 03, 2007. Female patient, 56 years of age, was diagnosed with agitation, psychotic disorder and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, aspiration, crepitations, dysphagia, dysphonia, malnutrition, orthostatic hypotension, parkinsonism, productive cough. DIAZEPAM dosage: 10 MG (10 MG, 1 IN 1 D). During the same period patient was treated with HALOPERIDOL, PROCYCLIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Health Professional from UNITED STATES on May 21, 2007. Male patient, 15 years of age, weighting 74.96 lb, was diagnosed with gastrointestinal pain and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: aphasia, asthenia, blood creatinine increased, blood pressure decreased, dyspnoea, facial palsy, feeling hot, headache. DIAZEPAM dosage: 1.6 MG Q 6 HRS IV. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on May 23, 2007. Female patient, 66 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: headache, nausea, vomiting. DIAZEPAM dosage: unknown. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2007. Female patient, 27 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: convulsion. DIAZEPAM dosage: unknown. During the same period patient was treated with ZUCLOPENTHIXOL, LITHIUM CARBONATE, PROCYCLIDINE HYDROCHLORIDE, RISPERDAL. Patient recovered.

Physician from UNITED STATES reported DIAZEPAM problem on May 18, 2007. Male patient, 53 years of age, was diagnosed with mania and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, condition aggravated, homicidal ideation, insomnia, irritability, laboratory test abnormal. DIAZEPAM dosage: unknown. During the same period patient was treated with COGENTIN, DDAVP, DEPAKOTE, COLACE. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 42 years of age, was treated with DIAZEPAM. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, COCAINE. Patient died on 01/01/2003.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on June 05, 2007. Female patient, 46 years of age, was treated with DIAZEPAM. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE. Patient died on 01/01/2003.

DIAZEPAM problem was reported by a Physician from UNITED STATES on June 05, 2007. Female patient was diagnosed with pain and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, accident, amnesia, arthralgia, cauda equina syndrome, chest pain, complex regional pain syndrome, constipation. DIAZEPAM dosage: 15 MG; QD; PO. During the same period patient was treated with OXYCODONE, LORAZEPAM, CLONIDINE, CARISOPRODOL, METHADONE, ETHCHLORVYNOL. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED KINGDOM reported DIAZEPAM problem on June 06, 2007. Male patient, 44 years of age, was diagnosed with myocardial infarction and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: pruritus, rash maculo-papular. DIAZEPAM dosage: 2 MG;QD;PO. During the same period patient was treated with CLOPIDOGREL, OMEGA, ATORVASTATIN, ASPIRIN, METOPROLOL SUCCINATE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from GERMANY on June 18, 2007. Male patient, 71 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, cognitive disorder, elevated mood, memory impairment. DIAZEPAM dosage: unknown. During the same period patient was treated with DICLOFENAC, DULOXETINE, CORTISONE ACETATE, VALORON N SOLUTION, VALORON N RETARD. Patient recovered.

Health Professional from PORTUGAL reported DIAZEPAM problem on July 03, 2006. Female patient, child 5 years of age, weighting 66.14 lb, was diagnosed with varicella and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: hypoalbuminaemia, sepsis, skin swelling, staphylococcal infection, toxic epidermal necrolysis. DIAZEPAM dosage: unknown. During the same period patient was treated with BENZYLPENICILLIN, RISPERIDONE, DOCUSATE, BACLOFEN, MAGNESIUM HYDROXIDE, CLONAZEPAM, AMOXICILLIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Physician from SWEDEN on July 13, 2006. Male patient, weighting 4.41 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, apgar score low, autism, bradycardia neonatal, caesarean section, eye rolling, foetal growth retardation. DIAZEPAM dosage: 17.5 MG OTH TL. During the same period patient was treated with HALOPERIDOL, HEPARIN, BETAMETHASONE, BUDESONIDE, FENOTEROLHYDROBROMID, LEVOMEPROMAZIN, PREDNISOLONE, TERBUTALINE SULPHATE. Patient recovered.

Physician from AUSTRALIA reported DIAZEPAM problem on May 25, 2006. Male patient, 19 years of age, was diagnosed with schizophrenia and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, myositis. DIAZEPAM dosage: unknown. During the same period patient was treated with CLOZARIL. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 61 years of age, was diagnosed with status epilepticus and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: alcohol withdrawal syndrome, anion gap increased, blood bicarbonate decreased, blood ph decreased. DIAZEPAM dosage: 4850 MG IV. During the same period patient was treated with PHENYTOIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Aug 17, 2006. Male patient, 34 years of age, was diagnosed with convulsion and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood osmolarity increased, metabolic function test abnormal. DIAZEPAM dosage: 20MG IV. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 60 years of age, was diagnosed with convulsion and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood lactic acid increased, blood osmolarity increased, laboratory test abnormal, osmolar gap abnormal. DIAZEPAM dosage: 290MG IV. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported DIAZEPAM problem on Aug 17, 2006. Male patient, 35 years of age, was diagnosed with alcohol withdrawal syndrome and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: blood osmolarity increased, metabolic function test abnormal, osmolar gap abnormal. DIAZEPAM dosage: 2,450MG IV. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Health Professional from UNITED STATES on Aug 21, 2006. Female patient, weighting 158.0 lb, was diagnosed with anxiety and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: asthenia, headache, heart rate increased, nausea. DIAZEPAM dosage: 10 MG THREE TIMES DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Aug 11, 2006. Female patient, 36 years of age, weighting 195.0 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: accidental overdose, hepatic failure, hepatic steatosis, renal failure, road traffic accident. DIAZEPAM dosage: unknown. During the same period patient was treated with IMIPRAMINE, METHADONE, BUDEPRION, DESIPRAMINE, QUETIAPINE. Patient died on 05/01/2006.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 15, 2006. Female patient, 54 years of age, was diagnosed with hypertension and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: electrocardiogram st segment depression, hypotension, intentional overdose, sinus tachycardia. DIAZEPAM dosage: unknown. During the same period patient was treated with COAPROVEL, ACETAMINOPHEN, ALCOHOL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DIAZEPAM problem on Aug 30, 2006. Male patient, 51 years of age, was diagnosed with panic disorder and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: rash pruritic, urticaria. DIAZEPAM dosage: 10MG 3 TIMES DAILY ORALLY. During the same period patient was treated with DEXEDRINE, EFFEXOR, RISPERDAL. Patient recovered.

DIAZEPAM problem was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Female patient, 64 years of age, weighting 232.0 lb, was diagnosed with anxiety and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. DIAZEPAM dosage: 5 MG TID PRN PO. Patient recovered.

Pharmacist from AUSTRALIA reported DIAZEPAM problem on Aug 10, 2006. Female patient, weighting 143.3 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. DIAZEPAM dosage: unknown. During the same period patient was treated with RIVOTRIL, IMOVANE, ENDEP. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from DENMARK on Sept 07, 2006. Female patient, 54 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: electrocardiogram st segment depression, hypotension, sinus tachycardia. DIAZEPAM dosage: unknown. During the same period patient was treated with ALCOHOL, PARACETAMOL, COAPROVEL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DIAZEPAM problem on Sept 11, 2006. Female patient was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: malaise, nausea. DIAZEPAM dosage: 5 MG TID. Patient recovered.

DIAZEPAM problem was reported by a Pharmacist from UNITED STATES on Sept 08, 2006. Male patient, 50 years of age, weighting 141.8 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: haematemesis, intentional overdose, nausea, self-injurious ideation. DIAZEPAM dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DIAZEPAM problem on Sept 14, 2006. Female patient, 61 years of age, weighting 200.0 lb, was diagnosed with anxiety, pain and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, pruritus, rash. DIAZEPAM dosage: unknown. Patient recovered.

DIAZEPAM problem was reported by a Physician from SWEDEN on Sept 25, 2006. Male patient, 16 years of age, weighting 132.3 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: amnesia, disorientation, gait disturbance, unevaluable event. DIAZEPAM dosage: unknown. During the same period patient was treated with ROACCUTAN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Sept 18, 2006. Male patient, 74 years of age, weighting 194.0 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: confusional state, hypotension, metabolic encephalopathy, pyrexia, somnolence, toxic induced encephalopathy. DIAZEPAM dosage: unknown. During the same period patient was treated with HYDROCODONE, AMBIEN, DOXEPIN, OXYCONTIN, METFORMIN, LANTUS. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 43 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: aortic arteriosclerosis, fall, hepatic congestion, pleural adhesion, pulmonary congestion. DIAZEPAM dosage: unknown. During the same period patient was treated with BENZOYLECOGNINE, OXYCODONE, PAROXETINE, QUETIAPINE FUMARATE. Patient died.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Sept 27, 2006. Male patient, 43 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, hepatic steatosis, loss of consciousness, pulmonary oedema. DIAZEPAM dosage: unknown. During the same period patient was treated with VERAPAMIL, QUETIAPINE FUMARATE, BUPROPION, PAROXETINE, ZOLPIDEM TARTRATE, ETHANOL. Patient died.

DIAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 56 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema, visceral oedema. DIAZEPAM dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, PHENYTOIN, QUETIAPINE FUMARATE. Patient died.

Consumer or non-health professional from UNITED STATES reported DIAZEPAM problem on Sept 27, 2006. Male patient, 46 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema. DIAZEPAM dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, METHADONE, NORTRIPTYLINE, FLUOXETINE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 09, 2006. Male patient, 61 years of age, was diagnosed with convulsion and was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, alcohol withdrawal syndrome, anion gap increased, blood osmolarity increased, blood ph decreased, hypertension, pyrexia, tachycardia. DIAZEPAM dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported DIAZEPAM problem on Oct 16, 2006. Male patient, 74 years of age, weighting 205.9 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: chills, confusional state, encephalopathy, hypotension, mental status changes, pyrexia, somnolence. DIAZEPAM dosage: 5+2.5MG TAKEN AT BEDTIME. During the same period patient was treated with DOXEPIN, HYDROCODONE, AMBIEN. Patient was hospitalized. Patient recovered.

DIAZEPAM problem was reported by a Health Professional from UNITED STATES on Oct 18, 2006. Male patient, 74 years of age, weighting 205.9 lb, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: chills, confusional state, hypotension, mental impairment, metabolic encephalopathy, pyrexia, somnolence, toxic induced encephalopathy. DIAZEPAM dosage: 7.5 MG, QHS, ORAL. During the same period patient was treated with DOXEPIN, HYDROCODONE BITARTRATE, AMBIEN, OXYCONTIN, METFORMIN, LANTUS. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 53 years of age, was treated with DIAZEPAM. DIAZEPAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE, MORPHINE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 19 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 47 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 53 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, QUETIAPINE FUMARATE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 30 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, OXYCODONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 53 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. DIAZEPAM dosage: unknown. During the same period patient was treated with CARISOPRODOL, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 39 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with DESIPRAMINE, HYDROCODONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 44 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 59 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 33 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, MARIJUANA, ADDITIONAL SUBSTANCES NOT LISTED IN REPORT. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 38 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. DIAZEPAM dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, DILTIAZEM, ADDITIONAL SUBSTANCES NOT LISTED IN REPORT. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 67 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with CLONIDINE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 47 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 21 years of age, was treated with DIAZEPAM. DIAZEPAM dosage: unknown. During the same period patient was treated with ALPRAZOLAM, OXYCODONE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 51 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE, OXYCODONE, ADDITIONAL SUBSTANCES NOT LISTED IN REPORT. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 62 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE, POTASSIUM CHLORIDE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 51 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE, TRICYCLIC ANTIDEPRESSANT. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 44 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 47 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, poisoning, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 19 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 53 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: poisoning. DIAZEPAM dosage: unknown. During the same period patient was treated with MORPHINE, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 62 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE, POTASSIUM CHLORIDE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 21 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: poisoning. DIAZEPAM dosage: unknown. During the same period patient was treated with ALPRAZOLAM, OXYCODONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 51 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE, METHADONE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 47 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with OXYCODONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 67 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, poisoning, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with CLONIDINE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 53 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. DIAZEPAM dosage: unknown. During the same period patient was treated with CARISOPROLOL, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 39 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with DESIPRAMINE, HYDROCODONE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 35 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE, METHADONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 20 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, poisoning, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 24 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, poisoning, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

DIAZEPAM problem was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 46 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, completed suicide, respiratory arrest. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

Physician from UNITED STATES reported DIAZEPAM problem on Oct 24, 2006. Female patient, 59 years of age, was treated with DIAZEPAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. DIAZEPAM dosage: unknown. During the same period patient was treated with METHADONE. Patient died.

Showing 1-75 of 203 Next >

Ask Our Patient Community about DIAZEPAM

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
Phenergan